8-K: MDWerks Stock Transitions to OTC Expert Market Due to Late Annual Filing

MDWerks, Inc. has transitioned to the OTC Expert Market due to a delay in filing its annual report for the fiscal year ended December 31, 2023.

Summary

• MDWerks, Inc. has announced that its common stock has moved to the OTC Expert Market under the ticker symbol MDWK.
• This transition occurred because the company failed to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, on time.
• The company had previously reported a delay in filing on Form 12b-25 on April 1, 2024.
• The delay is due to the need for more time to complete year-end procedures, including the audit of financial statements.
• MDWerks is working to complete the necessary work to file the Form 10-K as soon as possible.
• The company aims to restore its trading status on the OTC Markets Pink Market.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the company's failure to file its annual report on time and the subsequent transition to the OTC Expert Market. This indicates potential financial and operational issues.

Positives

• MDWerks is actively working to complete the necessary procedures to file the Form 10-K.
• The company is aiming to restore its trading status on the OTC Markets Pink Market.

Negatives

• MDWerks failed to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, on time.
• The company's stock has transitioned to the OTC Expert Market, which is a less liquid market than the Pink Market.

Risks

• The company's failure to file its annual report on time could lead to further regulatory scrutiny.
• The transition to the OTC Expert Market may negatively impact the company's stock price and liquidity.
• There is a risk that the company may not be able to complete the necessary procedures to file the Form 10-K in a timely manner.
• The company's future financial performance may be affected by the delay in filing.

Future Outlook

The company is working diligently to complete the necessary work to file the Form 10-K as soon as practicable in order to restore its trading status on OTC Markets Pink Market. The company has made forward looking statements regarding future performance, but cautions investors not to rely unduly on these statements.

Management Comments

• The company is working diligently to complete the necessary work to file the Form 10-K as soon as practicable.
• The company aims to restore its trading status on the OTC Markets Pink Market.

Industry Context

The transition to the OTC Expert Market is a consequence of the company's failure to meet SEC filing deadlines, which is a concern for investors and regulators. This situation highlights the importance of timely and accurate financial reporting for publicly traded companies.

Comparison to Industry Standards

• The failure to file an annual report on time is a significant deviation from industry standards for publicly traded companies.
• Most companies listed on major exchanges or the OTC Markets Pink Market are expected to file their annual reports within the prescribed deadlines.
• Companies that fail to meet these deadlines often face increased scrutiny from regulators and investors.
• The transition to the OTC Expert Market is a negative outcome, as it indicates a lack of compliance with reporting requirements.

Stakeholder Impact

• Shareholders may experience a decrease in the value of their investment due to the transition to the OTC Expert Market.
• The company's reputation may be negatively impacted by the late filing.
• Employees may be concerned about the company's financial stability.

Next Steps

• MDWerks needs to complete the audit of its financial statements.
• MDWerks needs to file its Form 10-K with the SEC.
• MDWerks needs to restore its trading status on the OTC Markets Pink Market.

Key Dates

Keywords

OTC Expert Market, Form 10-K, Annual Report, Late Filing, MDWerks, MDWK, OTC Markets Pink Market, SEC, Financial Statements, Audit